Enhancing Anti-Tumor Immunity in Mice with MHC Class II Gene Transfection
Author Information
Author(s): C Mongini, M S'anchez Lockhart, CI Waldner, EMC Alvarez, MJ Gravisaco, MI Roig, SE Hajos
Primary Institution: Catedra de Immunologia, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires
Hypothesis
Does the transfection of MHC class II genes into a murine leukemia cell line enhance anti-tumor immunity?
Conclusion
Transfecting MHC class II genes into tumor cells significantly enhances the anti-tumor immune response in syngeneic mice.
Supporting Evidence
- Transfected cells showed enhanced expression of MHC class II molecules.
- Mice injected with transfected cells had a significantly higher survival rate.
- Specific cytotoxic T cell responses were significantly increased in mice immunized with transfected cells.
Takeaway
Scientists found that adding a special gene to cancer cells helps the immune system fight the cancer better, making it harder for the cancer to grow.
Methodology
Mice were injected with transfected tumor cells, and their immune response was measured through survival rates and cytotoxic T cell activity.
Limitations
The study was conducted in a specific mouse model, which may not fully represent human responses.
Participant Demographics
Two to four month old normal BALB/c mice were used.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website